DeepMed Research

INSIGHTEC, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study of ExAblate Focused Ultrasound Ablation of Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Device: ExAblate MRgFUS

First Posted Date: 2012-06-15

Last Posted Date: 2016-08-31

Lead Sponsor: InSightec

Target Recruit Count: 14

Registration Number: NCT01620359

Locations: 🇩🇪
Marienhospital, Bottrop, Germany

ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors

Not Applicable

Active, not recruiting

Conditions: Glioma
Metastatic Brain Cancer

Interventions: Device: ExAblate Transcranial System

First Posted Date: 2011-11-17

Last Posted Date: 2025-05-01

Lead Sponsor: InSightec

Target Recruit Count: 10

Registration Number: NCT01473485

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids

Not Applicable

Withdrawn

Conditions: Uterine Fibroids
Pelvic Pain
Bleeding

Interventions: Device: Exablate 2100
Procedure: Myomectomy

First Posted Date: 2011-04-04

Last Posted Date: 2018-06-15

Lead Sponsor: InSightec

Registration Number: NCT01328067

Locations: 🇬🇧
St. Mary's Hospital, London, United Kingdom

ExAblate Transcranial MR Guided Focused Ultrasound in the Treatment of Essential Tremor

Phase 1

Completed

Conditions: Essential Tremor

Interventions: Device: ExAblate Transcranial MRgFUS System

First Posted Date: 2011-02-25

Last Posted Date: 2013-08-26

Lead Sponsor: InSightec

Target Recruit Count: 15

Registration Number: NCT01304758

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

Not Applicable

Completed

Conditions: Uterine Fibroids

Interventions: Device: ExAblate Treatment UF V2

First Posted Date: 2011-01-28

Last Posted Date: 2019-03-06

Lead Sponsor: InSightec

Target Recruit Count: 108

Registration Number: NCT01285960

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Duke University, Durham, North Carolina, United States

and more 5 locations

Safety and Efficacy of MRgFUS for the Treatment of Low Back Pain

Phase 2

Completed

Conditions: Lower Back Pain, Facets Joints Osteoarthritis

First Posted Date: 2010-11-02

Last Posted Date: 2012-02-22

Lead Sponsor: InSightec

Target Recruit Count: 50

Registration Number: NCT01232582

Locations: 🇮🇱
Sheba MC, Ramat Gan, Israel
🇬🇧
St. Mary's Hospital, London, United Kingdom

Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility Study

Not Applicable

Completed

Conditions: Localized Low-Intermediate Risk Prostate Cancer

Interventions: Device: MRgFUS Treatment

First Posted Date: 2010-10-22

Last Posted Date: 2019-03-13

Lead Sponsor: InSightec

Target Recruit Count: 8

Registration Number: NCT01226576

Locations: 🇮🇱
Sheba Medical Center, Tel Hashomer, Israel
🇸🇬
National Cancer Center Singapore, Singapore, Singapore
🇨🇦
University Health Network, Toronto, Ontario, Canada

and more 2 locations

Safety Study of ExAblate for the Treatment of Uterine Fibroids

Not Applicable

Completed

Conditions: Uterine Fibroids

Interventions: Device: ExAblate

First Posted Date: 2010-06-11

Last Posted Date: 2019-03-19

Lead Sponsor: InSightec

Target Recruit Count: 121

Registration Number: NCT01142791

Locations: 🇺🇸
Borgess Research Institute, Kalamazoo, Michigan, United States
🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
University Image Guided Therapy, Boca Raton, Florida, United States

and more 5 locations

A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids

Not Applicable

Completed

Conditions: Bleeding
Pain
Uterine Fibroids

Interventions: Device: Exablate 2100

First Posted Date: 2010-03-25

Last Posted Date: 2012-02-22

Lead Sponsor: InSightec

Target Recruit Count: 40

Registration Number: NCT01092988

Locations: 🇮🇱
Sheba MC, Ramat Gan, Israel
🇫🇷
Radiopharmaceutiques hopital Bretonneau, Tours, France
🇷🇺
Research Centre of Obstetric / Gynaecology & Perinatology, Moscow, Russian Federation

and more 1 locations

Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma

Not Applicable

Completed

Conditions: Bone Cancer
Pain
Bone Metastases

Interventions: Radiation: Radiation
Device: Exablate treatment

First Posted Date: 2010-03-24

Last Posted Date: 2019-03-13

Lead Sponsor: InSightec

Target Recruit Count: 60

Registration Number: NCT01091883

Locations: 🇨🇳
Taipei Medical University Hospital, Taipei city, Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy